{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:15:57Z","timestamp":1744344957807,"version":"3.40.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"DOI":"10.7759\/cureus.82019","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:16:32Z","timestamp":1744301792000},"source":"Crossref","is-referenced-by-count":0,"title":["Robot-Assisted Radical Prostatectomy: Concordance and Correlation Between Preoperative Positron Emission Tomography-Computed Tomography With Prostate-Specific Membrane Antigen (PET-CT PSMA) and Final Histopathological Report"],"prefix":"10.7759","author":[{"given":"Jose  R","family":"Vazquez Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos M","family":"Vasquez Lastra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian  I","family":"Villeda Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Martinez Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco  A","family":"Santacruz Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019, 10:63-89. 10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"ref2","unstructured":"World. (2020). Accessed. 2024: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/900-world-fact-sheet.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133184","article-title":"Incidence, mortality, and trends of prostate cancer in Mexico from 2000 to 2019: results from the global burden of disease study 2019","volume":"14","author":"Beltran-Ontiveros SA","year":"2022","unstructured":"Beltran-Ontiveros SA, Fernandez-Galindo MA, Moreno-Ortiz JM, et al.. Incidence, mortality, and trends of prostate cancer in Mexico from 2000 to 2019: results from the global burden of disease study 2019. Cancers (Basel). 2022, 14:3184. 10.3390\/cancers14133184","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112594","article-title":"PSMA PET-CT in the diagnosis and staging of prostate cancer","volume":"12","author":"Combes AD","year":"2022","unstructured":"Combes AD, Palma CA, Calopedos R, Wen L, Woo H, Fulham M, Leslie S. PSMA PET-CT in the diagnosis and staging of prostate cancer. Diagnostics (Basel). 2022, 12:2594. 10.3390\/diagnostics12112594","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.203877","article-title":"A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies","volume":"59","author":"O'Keefe DS","year":"2018","unstructured":"O'Keefe DS, Bacich DJ, Huang SS, Heston WD. A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies. J Nucl Med. 2018, 59:1007-13. 10.2967\/jnumed.117.203877","journal-title":"J Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.26","article-title":"Current use of PSMA-PET in prostate cancer management","volume":"13","author":"Maurer T","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use of PSMA-PET in prostate cancer management. Nat Rev Urol. 2016, 13:226-35. 10.1038\/nrurol.2016.26","journal-title":"Nat Rev Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.23912","article-title":"Diagnostic accuracy of 68Ga-PSMA PET\/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis","volume":"216","author":"Satapathy S","year":"2021","unstructured":"Satapathy S, Singh H, Kumar R, Mittal BR. Diagnostic accuracy of 68Ga-PSMA PET\/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2021, 216:599-607. 10.2214\/AJR.20.23912","journal-title":"AJR Am J Roentgenol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4255-1","article-title":"Diagnostic performance of 68Ga-PSMA PET\/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms","volume":"46","author":"Zhang J","year":"2019","unstructured":"Zhang J, Shao S, Wu P, et al.. Diagnostic performance of 68Ga-PSMA PET\/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms. Eur J Nucl Med Mol Imaging. 2019, 46:908-20. 10.1007\/s00259-018-4255-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref9","article-title":"PSMA PET\/CT and standard plus PET\/CT-ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies","volume":"61","author":"Liu C","year":"2020","unstructured":"Liu C, Liu T, Zhang Z, et al.. PSMA PET\/CT and standard plus PET\/CT-ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies. J Nucl Med. 2020, 61:1314-9.","journal-title":"J Nucl Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7150\/thno.58140","article-title":"Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68Ga-PSMA PET\/CT: a real-world study","volume":"11","author":"Jiao J","year":"2021","unstructured":"Jiao J, Kang F, Zhang J, et al.. Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68Ga-PSMA PET\/CT: a real-world study. Theranostics. 2021, 11:8396-411. 10.7150\/thno.58140","journal-title":"Theranostics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.07.006","article-title":"How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography\/computed tomography (68Ga-PSMA PET\/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node-based analyses","volume":"40","author":"Erdem S","year":"2022","unstructured":"Erdem S, Simsek DH, Degirmenci E, et al.. How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography\/computed tomography (68Ga-PSMA PET\/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node-based analyses. Urol Oncol. 2022, 40:6.e1-9. 10.1016\/j.urolonc.2021.07.006","journal-title":"Urol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14944","article-title":"Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature","volume":"125","author":"Luiting HB","year":"2020","unstructured":"Luiting HB, van Leeuwen PJ, Busstra MB, et al.. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. BJU Int. 2020, 125:206-14. 10.1111\/bju.14944","journal-title":"BJU Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer EM","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al.. Prostate cancer, version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023, 21:1067-96. 10.6004\/jnccn.2023.0050","journal-title":"J Natl Compr Canc Netw"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22441","article-title":"Diagnostic performance of 68Gallium-PSMA-11 PET\/CT to detect significant prostate cancer and comparison with 18FEC PET\/CT","volume":"8","author":"Hoffmann MA","year":"2017","unstructured":"Hoffmann MA, Miederer M, Wieler HJ, Ruf C, Jakobs FM, Schreckenberger M. Diagnostic performance of 68Gallium-PSMA-11 PET\/CT to detect significant prostate cancer and comparison with 18FEC PET\/CT. Oncotarget. 2017, 8:111073-83. 10.18632\/oncotarget.22441","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.01.079","article-title":"68Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study","volume":"200","author":"Lopci E","year":"2018","unstructured":"Lopci E, Saita A, Lazzeri M, et al.. 68Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study. J Urol. 2018, 200:95-103. 10.1016\/j.juro.2018.01.079","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000906","article-title":"Gallium 68-PSMA PET\/CT for lesion characterization in suspected cases of prostate carcinoma","volume":"39","author":"Sasikumar A","year":"2018","unstructured":"Sasikumar A, Joy A, Pillai AM, et al.. Gallium 68-PSMA PET\/CT for lesion characterization in suspected cases of prostate carcinoma. Nucl Med Commun. 2018, 39:1013-21. 10.1097\/MNM.0000000000000906","journal-title":"Nucl Med Commun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/iju.IJU_91_19","article-title":"Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng\/ml","volume":"35","author":"Kumar N","year":"2019","unstructured":"Kumar N, Yadav S, Kumar S, Saurav K, Prasad V, Vasudeva P. Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng\/ml. Indian J Urol. 2019, 35:202-7. 10.4103\/iju.IJU_91_19","journal-title":"Indian J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345964-robot-assisted-radical-prostatectomy-concordance-and-correlation-between-preoperative-positron-emission-tomography-computed-tomography-with-prostate-specific-membrane-antigen-pet-ct-psma-and-final-histopathological-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:16:34Z","timestamp":1744301794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345964-robot-assisted-radical-prostatectomy-concordance-and-correlation-between-preoperative-positron-emission-tomography-computed-tomography-with-prostate-specific-membrane-antigen-pet-ct-psma-and-final-histopathological-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.82019","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}